April 30th 2025
Respiratory diseases made up the hospitalizations in older adults after they were exposed to wildfire smoke.
April 28th 2025
Smoking prevalence is projected to decline by 2035, yet health consequences persist due to slower reductions among older adults.
February 13th 2025
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline at 52 weeks in the phase 3 FIBRONEER-ILD trial.
December 16th 2024
Both candidates combine 2 already licensed vaccines to prevent influenza and COVID-19.
December 10th 2024
These data from the Environmental Protection Agency were presented at the Society for Risk Analysis annual meeting.
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies